Tweets
RheumNow’s expanded coverage of the #ACR21 annual meeting is sponsored in part by @bmsnews, @JanssenUS, @Novartis. All content chosen by RheumNow & its faculty.
Dr. John Cush @RheumNow ( View Tweet )
4 years 8 months ago
DCVAS testing results in GCA. @davidliew @philipcrobinson are you guys essentially not imaging anyone in anyway? What's going on? #ACR21 @RheumNow https://t.co/IMr5ee2Iea
Richard Conway @RichardPAConway ( View Tweet )
4 years 8 months ago
Billing and coding expert, Jean Acevedo shares the three URLs that you need to best understand the updated 2021 EM coding! #ACR21 @RheumNow #RheumNow https://t.co/3HbDuZP8gC
Dr. Rachel Tate @uptoTate ( View Tweet )
4 years 8 months ago
Pulmonary Arterial Hypertension in #AOSD
Rare but severe complication - life threatening
French study of 13 pts - network dataset. ALL FEMALES!
Age 32, mean f/u 34 mths, 5 pts (38.5%) DIED
@RheumNow #ACRBest abst#1100 https://t.co/5LIzHagesP
Bella Mehta @bella_mehta ( View Tweet )
4 years 8 months ago
Towards better assessment and management of multimorbidity by Dr. Mrinalini Dey ( @DrMiniDey ) #ACR21
https://t.co/7DPGsVB6bG https://t.co/F57k44AWZ4
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 8 months ago
Knowledge Bowl at #ACR21
⭐️Approximately half of patients with IIM who develop pneumomediastinum have this subtype of dermatomyositis.
➡️Amyopathic (MDA5) dermatomyositis
@RheumNow
Meral K. El Ramahi, MD @MeralElRamahiMD ( View Tweet )
4 years 8 months ago
Knowledge Bowl at #ACR21
⭐️In a suspected PAN case, you order a peripheral smear to look for this potential etiology,
➡️Hairy cells
@RheumNow
Meral K. El Ramahi, MD @MeralElRamahiMD ( View Tweet )
4 years 8 months ago
JAK-pot registry-based study. Following JAKi failure should you switch mode of action or go to second JAKi? Both seem equally effective in terms of drug retention. Didn't matter if switch for efficacy or adverse event. Abstr#1442 #ACR21 @RheumNow https://t.co/QEBB3flArC
Richard Conway @RichardPAConway ( View Tweet )
4 years 8 months ago
#ACR21 Abs#1442: JAKpot - Cycle JAK or switch to bDMARD after JAK failure?
▶️No difference between cycle vs bDMARD group
▶️Non-signif trends: cycled JAK better for inefficacy to 1st JAK, bDMARD better for adverse effects
@Rheumnow https://t.co/6UNUVh5ZW8 https://t.co/upfI6tDH1p
Links:
Eric Dein @ericdeinmd ( View Tweet )
4 years 8 months ago
First JAKi failure: What's next? Wanna find out? It's here
https://t.co/o5CE1MBzUu
Abstr#1442 #ACR21 @RheumNow https://t.co/f0sdPn5mcZ
Aurelie Najm @AurelieRheumo ( View Tweet )
4 years 8 months ago
Trauma associates with subsequent increased flares of SLE. Abstr#1446 #ACR21 @RheumNow https://t.co/QeNXOjHAjn
Richard Conway @RichardPAConway ( View Tweet )
4 years 8 months ago
Tell me there's no collegiality on the #ACR21 virtual platform!
kudos to @ACRheum for making this thing run so smoothly, year-on-year
(and I'm telling you, the value's in the chat and the questions)
@RheumNow @Janetbirdope https://t.co/XJZArHIdnc
David Liew @drdavidliew ( View Tweet )
4 years 8 months ago
